Search in:

Pharmacogenomics and Personalized Medicine Volume 12, 2019 - Issue

Submit an article Journal homepage

Open access

1,218

Views

CrossRef citations to date

Altmetric

Review

Personalized medicine in breast cancer: pharmacogenomics approaches

Shabnam Jeibouei1 Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Esmael Akbari2 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Alireza Kalbasi3 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Amir Reza Aref4 Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA;5 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Mohammad Ajoudanian6 Department of Tissue Engineering and Applied Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Alireza Rezvani7 Department of Hematology, Medical Oncology and Stem Cell Transplantation, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Hakimeh Zali8 Proteomics Research Centre, Department of Tissue Engineering and Applied Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IranCorrespondence[email protected]

show all

Pages 59-73 | Published online: 27 May 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (24)

Sherin Shaaban & Yuan Ji. (2023) Pharmacogenomics and health disparities, are we helping?. Frontiers in Genetics 14.
Crossref

Nasr M. A. Allahloubi, Abdel-Rahman N. Zekri, Mohamed Ragab, Marwa Mohanad, Ola S. Ahmed, Salem Eid, Mohamed Ghareeb, Iman Gouda & Abeer A. Bahnassy. (2022) Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. Biochemical Genetics 60:6, pages 1963-1985.
Crossref

Shabnam Jeibouei, Forough Shams, Fariba Mohebichamkhorami, Davood Sanooghi, Bahareh Faal, Mohammad Esmaeil Akbari & Hakimeh Zali. (2022) Biological and clinical review of IORT-induced wound fluid in breast cancer patients. Frontiers in Oncology 12.
Crossref

Nilofer Shaikh, Sanket Bapat, Muthukumarasamy Karthikeyan & Renu Vyas. (2022) A Review on Computational Analysis of Big Data in Breast Cancer for Predicting Potential Biomarkers. Current Topics in Medicinal Chemistry 22:21, pages 1793-1810.
Crossref

Thalita Basso Scandolara, Bruno Ricardo Barreto Pires, Beatriz Vacario, Isis Salviano Soares de Amorim, Priscyanne Barreto Siqueira, Juliana Mara Serpeloni, André Luiz Mencalha, Cibele Rodrigues Bonvicino & Carolina Panis. (2022) An Overview Regarding Pharmacogenomics and Biomarkers Discovery: Focus on Breast Cancer. Current Topics in Medicinal Chemistry 22:20, pages 1654-1673.
Crossref

Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna M. Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappalà, Francesco P. Cammarata, Giorgio Russo, Massimo Ippolito, Giacomo Cuttone, Giovanni Li Volti, Nunzio Vicario & Rosalba Parenti. (2022) The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression. Biomedicines 10:4, pages 806.
Crossref

Bárbara Costa & Nuno Vale. (2022) Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer. International Journal of Molecular Sciences 23:6, pages 3181.
Crossref

Covenant Ogbonna & Doga Kavaz. (2022) Development of novel silver-apple pectin nanocomposite beads for antioxidant, antimicrobial and anticancer studies. Biologia 77:3, pages 879-891.
Crossref

Clarissa Lemmen, Dusan Simic & Stephanie Stock. (2021) A Vision of Future Healthcare: Potential Opportunities and Risks of Systems Medicine from a Citizen and Patient Perspective—Results of a Qualitative Study. International Journal of Environmental Research and Public Health 18:18, pages 9879.
Crossref

Heather H. C. Lau, Martin Ingelsson & Joel C. Watts. (2020) The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease. Acta Neuropathologica 142:1, pages 17-39.
Crossref

Fatima Noor, Ayesha Noor, Ali Raza Ishaq, Iqra Farzeen, Muhammad Hamzah Saleem, Kanwal Ghaffar, Muhammad Farhan Aslam, Sidra Aslam & Jen-Tsung Chen. (2021) Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review. Current Pharmaceutical Design 27:20, pages 2344-2365.
Crossref

Daniela Vasconcelos Lopes, Amanda de Fraga Dias, Luiz Fernando Lopes Silva, Juliete Nathali Scholl, Jean Sévigny, Ana Maria Oliveira Battastini & Fabrício Figueiró. (2021) Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth. Purinergic Signalling 17:2, pages 273-284.
Crossref

Apolonia Novillo, Ana Fernández-Santander, Maria Gaibar, Miguel Galán, Alicia Romero-Lorca, Fadoua El Abdellaoui-Soussi & Pablo Gómez-del Arco. (2021) Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer. Frontiers in Oncology 11.
Crossref

Leila Syedmoradi, Michael L. Norton & Kobra Omidfar. (2021) Point-of-care cancer diagnostic devices: From academic research to clinical translation. Talanta 225, pages 122002.
Crossref

Philip S. Bernard, Whitney Wooderchak-Donahue, Mei Wei, Steven M. Bray, Kevin C. Wood, Baiju Parikh & Gwendolyn A. McMillin. (2021) Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer. Cancers 13:6, pages 1219.
Crossref

Enrique Hernández-Lemus & Mireya Martínez-García. (2021) Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics. Frontiers in Oncology 10.
Crossref

Nerethika Ravichandiran, Muneesh Kumar Barman, Sai Tejaswi Lavuri, Manjita Srivastava, Shalini Sakthivel, Meenakshi Singh, Kailash Chand, Subash C. Sonkar & Prudhvilal Bhukya. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics 433 466 .

Clarissa Lemmen, Christiane Woopen & Stephanie Stock. (2021) Systems medicine 2030: A Delphi study on implementation in the German healthcare system. Health Policy 125:1, pages 104-114.
Crossref

Maria Ida Amabile, Federico Frusone, Alessandro De Luca, Domenico Tripodi, Giovanni Imbimbo, Silvia Lai, Vito D’Andrea, Salvatore Sorrenti & Alessio Molfino. (2020) Locoregional Surgery in Metastatic Breast Cancer: Do Concomitant Metabolic Aspects Have a Role on the Management and Prognosis in this Setting?. Journal of Personalized Medicine 10:4, pages 227.
Crossref

Fang-Ming Chen, Li-Ju Huang, Fu Ou-Yang, Jung-Yu Kan, Li-Chun Kao & Ming-Feng Hou. (2020) Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer. Breast Cancer Research and Treatment 183:1, pages 61-70.
Crossref

Kincső-Zsófia Lőrincz, Zsuzsánna Pap, Simona Lileana Mocan, Csanád-Endre Lőrincz & Beáta-Ágota Baróti. (2020) Ultrasound-Guided Core-Needle Biopsy of Suspicious Breast Lesions. Journal of Interdisciplinary Medicine 5:2, pages 48-55.
Crossref

Youn Kyung Choi, Jung-Il Kang, Sanghoon Han, Young Ree Kim, Jaemin Jo, Yong Woo Kang, Do Ryeon Choo, Jin Won Hyun, Young Sang Koh, Eun-Sook Yoo & Hee-Kyoung Kang. (2020) L-Ascorbic Acid Inhibits Breast Cancer Growth by Inducing IRE/JNK/CHOP-Related Endoplasmic Reticulum Stress-Mediated p62/SQSTM1 Accumulation in the Nucleus. Nutrients 12:5, pages 1351.
Crossref

Maria Gaibar, Laura Beltrán, Alicia Romero-Lorca, Ana Fernández-Santander & Apolonia Novillo. (2020) Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2 -Positive Breast Cancer . Journal of Oncology 2020, pages 1-13.
Crossref

Enrique Hernández-Lemus. 2020. Drug Repurposing in Cancer Therapy. Drug Repurposing in Cancer Therapy 191 211 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Personalized medicine in breast cancer: pharmacogenomics approaches

Articles from other publishers (24)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Personalized medicine in breast cancer: pharmacogenomics approaches

Citations (24)

Articles from other publishers (24)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date